ASPHD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ASPHD Antibodies for investigating aspartate beta-hydroxylase (ASPHD) in various biological processes. ASPHD Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Aspartate beta-hydroxylase functions as an essential enzyme in post-translational modification of proteins, influencing cellular signaling and development. ASPHD plays a crucial role in the synthesis of neuropeptides and regulation of neurotransmitter release, making it particularly relevant for neurobiology research. Current studies indicate significant implications for ASPHD in neurological disorders and disease progression. Investigating ASPHD expression patterns and activity levels can reveal important mechanisms in both normal physiology and pathological conditions. Research focusing on aspartate beta-hydroxylase continues to uncover new pathways and potential therapeutic targets. Understanding ASPHD regulation and function may lead to breakthroughs in treating various neurological conditions. Santa Cruz Biotechnology monoclonal antibodies for ASPHD research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.